Center for Human Embryonic Stem Cell Research and Education, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, California, United States of America.
PLoS One. 2010 Jun 7;5(6):e10979. doi: 10.1371/journal.pone.0010979.
Approximately 20% of oocytes are classified as immature and discarded following intracytoplasmic sperm injection (ICSI) procedures. These oocytes are obtained from gonadotropin-stimulated patients, and are routinely removed from the cumulus cells which normally would mature the oocytes. Given the ready access to these human oocytes, they represent a potential resource for both clinical and basic science application. However culture conditions for the maturation of cumulus-free oocytes have not been optimized. We aimed to improve maturation conditions for cumulus-free oocytes via culture with ovarian paracrine/autocrine factors identified by single cell analysis.
METHODOLOGY/PRINCIPAL FINDING: Immature human oocytes were matured in vitro via supplementation with ovarian paracrine/autocrine factors that were selected based on expression of ligands in the cumulus cells and their corresponding receptors in oocytes. Matured oocytes were artificially activated to assess developmental competence. Gene expression profiles of parthenotes were compared to IVF/ICSI embryos at morula and blastocyst stages. Following incubation in medium supplemented with ovarian factors (BDNF, IGF-I, estradiol, GDNF, FGF2 and leptin), a greater percentage of oocytes demonstrated nuclear maturation and subsequently, underwent parthenogenesis relative to control. Similarly, cytoplasmic maturation was also improved as indicated by development to blastocyst stage. Parthenogenic blastocysts exhibited mRNA expression profiles similar to those of blastocysts obtained after IVF/ICSI with the exception for MKLP2 and PEG1.
CONCLUSIONS/SIGNIFICANCE: Human cumulus-free oocytes from hormone-stimulated cycles are capable of developing to blastocysts when cultured with ovarian factor supplementation. Our improved IVM culture conditions may be used for obtaining mature oocytes for clinical purposes and/or for derivation of embryonic stem cells following parthenogenesis or nuclear transfer.
在胞浆内单精子注射(ICSI)程序后,约有 20%的卵母细胞被归类为不成熟并被丢弃。这些卵母细胞是从促性腺激素刺激的患者中获得的,通常从通常使卵母细胞成熟的卵丘细胞中取出。鉴于这些人类卵母细胞易于获得,它们代表了临床和基础科学应用的潜在资源。然而,无卵丘卵母细胞成熟的培养条件尚未得到优化。我们旨在通过使用通过单细胞分析鉴定的卵巢旁分泌/自分泌因子来改善无卵丘卵母细胞的成熟条件。
方法/主要发现:通过用卵巢旁分泌/自分泌因子补充不成熟的人类卵母细胞,在体外使卵母细胞成熟,这些因子是根据卵丘细胞中的配体及其在卵母细胞中的相应受体的表达选择的。成熟的卵母细胞被人工激活以评估发育能力。比较孤雌胚胎的基因表达谱与体外受精/ICSI 胚胎在桑椹胚和囊胚阶段。在用卵巢因子(BDNF、IGF-I、雌二醇、GDNF、FGF2 和瘦素)补充的培养基中孵育后,与对照相比,更多的卵母细胞表现出核成熟,随后进行孤雌生殖。同样,细胞质成熟也得到了改善,表现为发育到囊胚阶段。孤雌囊胚表现出与体外受精/ICSI 获得的囊胚相似的 mRNA 表达谱,除了 MKLP2 和 PEG1 之外。
结论/意义:从激素刺激周期中获得的无卵丘人类卵母细胞在培养时用卵巢因子补充可以发育到囊胚阶段。我们改进的 IVM 培养条件可用于获得成熟的卵母细胞用于临床目的,或者在孤雌生殖或核转移后获得胚胎干细胞。